An interventional study of Polyphenol-rich fruit and vegetable nutraceutical and Placebo in Cognitive Function and Healthy Volunteers, sponsored by Universidad Católica San Antonio de Murcia. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.
Sponsored by Universidad Católica San Antonio de Murcia · Not applicable, Interventional, and Basic science
The present research is a randomized, sex-stratified, cross-over and placebo-controlled clinical trial, designed to evaluate the effect of daily intake of a dietary supplement (Premium®) on cognitive function and psychological well-being compared to placebo.
It is indicated in numerous studies, that the content of fruits and vegetables, and therefore of the antioxidant compounds present, have a great capacity to neutralize free radicals, avoiding and preventing the deterioration of aging and degenerative diseases. The main effects tested are reducing the adverse effects caused by air pollution and free radicals that this causes in the organism that decreases oxidative damage, or exerting the ability of anti-inflammatory and neuroprotective effects. For example, in patients with kidney disease undergoing hemodialysis, a red grape supplement rich in polyphenols has demonstrated the ability to reduce the damage caused by oxidative stress.
The amount of bioactive compounds with antioxidants that are beneficial to the body varies according to the fruits and vegetables in question. For example, the pomegranate has a better antioxidant capacity than an apple and has values very similar to the different types of berries. This capacity depends on the amount of consumption of each of them, as well as the duration of consumption.
The mechanisms of action of this antioxidant activity in the body of the bioactive compound compounds that fruits and vegetables contain, have been determined in different previous research studies. In all cases, the antioxidant capacity shown by different fruits and vegetables depended on the concentration of polyphenols and enzymes of the kinase chain. For example, in the case of the prevention and control of type II diabetes, the main mechanism is diabetes by inhibiting the enzymes involved in the digestion of carbohydrates such as α-amylase or α-glucosidase or reducing agents. inflammation in diabetes with compromise in the metabolic syndrome and obesity with the corresponding oxidative stress.
In other cases, the effect of the combination of any of them has also been proven. Although the effect of these is positive, for example in the case of pomegranate and lemon, it shows that there is a positive synergy in both, the effect of the combination being better than separately The intervention of fruits and vegetables in cognition, for example, the improvement is associated with the decrease caused by age, shows a greater relationship in the case of flavonoids and especially anthocyanins and flavones.
The contracted would be in charge of the implementation and development of the following parts of the study, as well as the management and processing of obtained data, writing of scientific articles and help with the group's research tasks.
Study design. The contracted would carry out the recruitment phase. The randomized study, stratified by sex, crossed and controlled with placebo, designed to evaluate the effect of the daily intake of a dietary supplement on cognitive function and psychological well-being in comparison with placebo.
Duration of the study
The subjects will be evaluated and previously interviewed at the beginning of the study to know if they meet the inclusion / exclusion criteria.
Control appointments (the contracted will be responsible for monitoring and citing them): each volunteer will be controlled during the intervention period through 4 visits throughout the study. The visits will be made at the beginning and at the end of both phases of intervention. A period of time of ± 4 days will be established to make the visits. During each visit, determinations will be made regarding the different parameters studied.
Universidad Católica San Antonio de Murcia is the lead sponsor of 138 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dietary Supplement: Polyphenol-rich fruit and vegetable nutraceutical
Dietary Supplement: Placebo
Participants receive six capsules daily of a polyphenol-rich fruit, vegetable, and berry nutraceutical during the active 16-week intervention period.
Participants receive matching placebo capsules daily during the placebo 16-week intervention period.
Change in inhibitory control and selective attention measured by the Stroop Test
Inhibitory control and selective attention will be assessed using the Stroop Test. The primary endpoint is the change in Stroop Test performance from baseline to the end of each 16-week intervention period; higher performance indicates better cognitive function according to the scoring method used.
Time frame: Baseline to the end of each 16-week intervention period
Change in processing speed and cognitive flexibility measured by the Trail Making Test
Processing speed and cognitive flexibility will be assessed using the Trail Making Test. The outcome is the change in completion time from baseline to the end of each 16-week intervention period; shorter completion time indicates better performance.
Time frame: Baseline to the end of each 16-week intervention period
Change in verbal memory and logical reasoning measured by the Reynolds Intellectual Screening Test
Verbal memory and logical reasoning will be assessed using the Reynolds Intellectual Screening Test. The outcome is the change in test score from baseline to the end of each 16-week intervention period; higher scores indicate better cognitive performance.
Time frame: Baseline to the end of each 16-week intervention period
Change in blood brain-derived neurotrophic factor concentration
Blood samples will be analyzed to assess brain-derived neurotrophic factor concentration as a biomarker related to synaptic plasticity and neuroprotection.
Time frame: Baseline to the end of each 16-week intervention period
Change in blood cAMP response element-binding protein concentration
Blood samples will be analyzed to assess cAMP response element-binding protein concentration as a biomarker related to synaptic plasticity and neuroprotection.
Time frame: Baseline to the end of each 16-week intervention period
Plan to share: No
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Católica San Antonio de Murcia →